Specificity of antitumor immune reactions mediated by xenogeneic immune RNA
Abstract:
Evidence that xenogeneic immune RNA (I-RNA) mediated specific cytotoxic immune responses against human tumor-associated antigens was obtained from in vitro studies in two autologous melanoma systems. In these systems, malignant melanoma target cells, matching normal fibroblast target cells, lymphocyte effector cells, and melanoma and normal skin tissue used to immunize RNA donor animals were derived from the same autochthonous hosts. When incubated with autologous lymphocytes, I-RNA extracted from the lymphoid organs of donor animals immunized with melanoma tissue mediated immune reactions against autologous melanoma target cells in vitro. I-RNA from animals immunized with normal skin tissue from autochthonous hosts did not increase the cytotoxicity of autologous lymphocytes for autologous melanoma cells. Using autologous fibroblasts as target cells, we detected no increase in cytotoxicity when autologous lymphocytes were incubated with RNA from animals immunized either with melanoma tissue or normal skin tissue from the autochthonous host. By contrast, when allogeneic lymphocytes were used as effector cells, RNA extracted from animals immunized either with melanoma tissue or normal skin mediated cytotoxic immune reactions against melanoma target cells and normal fibroblast target cells derived from the same patient.
Insights
Xenogeneic immune RNA (I-RNA) from melanoma-immunized animals induced specific immune responses against melanoma cells in vitro. This immune RNA did not affect normal cells, suggesting targeted cancer immunotherapy potential.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Specific cytotoxic immune responses are crucial for effective cancer therapy.
- Tumor-associated antigens present potential targets for immune-mediated cancer treatments.
- Immune RNA (I-RNA) has shown promise in modulating immune responses.
Purpose of the Study:
- To investigate whether xenogeneic I-RNA can mediate specific cytotoxic immune responses against human tumor-associated antigens.
- To evaluate the specificity of I-RNA-mediated immune responses against melanoma cells versus normal cells.
- To explore the potential of I-RNA for targeted cancer immunotherapy.
Main Methods:
- In vitro studies using autologous melanoma systems.
- Extraction of I-RNA from lymphoid organs of donor animals immunized with melanoma tissue or normal skin.
- Incubation of I-RNA with autologous and allogeneic lymphocytes.
- Assessment of lymphocyte-mediated cytotoxicity against autologous melanoma target cells and normal fibroblast target cells.
Main Results:
- I-RNA from melanoma-immunized animals significantly increased the cytotoxicity of autologous lymphocytes against autologous melanoma target cells.
- I-RNA from animals immunized with normal skin did not enhance lymphocyte cytotoxicity against melanoma cells.
- No increased cytotoxicity was observed when using autologous fibroblasts as target cells, indicating specificity.
- Allogeneic lymphocytes, when incubated with I-RNA from either melanoma or normal skin immunization, showed cytotoxic reactions against both melanoma and fibroblast target cells.
Conclusions:
- Xenogeneic I-RNA derived from melanoma immunization can specifically induce cytotoxic immune responses against autologous melanoma cells in vitro.
- The findings suggest that I-RNA has the potential for developing targeted immunotherapies against human tumors.
- Further research is warranted to explore the therapeutic applications of I-RNA in cancer treatment.
Related Concept Videos
01:40Cell-mediated Immune Responses
01:20Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
01:26Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:28Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy